Cargando…
Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab
Graft survival rates after intestinal transplantation (ITx) are still the lowest in comparison to other solid organ transplants. One of the main reasons is the frequent occurrence of acute cellular rejection (ACR). Vedolizumab is an antibody against α4β7(+) integrin involved in gut-homing of T cells...
Autores principales: | Trentadue, Guido, Kats-Ugurlu, Gursah, Blokzijl, Tjasso, Diercks, Gilles FH, Haveman, Jan Willem, Faber, Klaas Nico, Dijkstra, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004630/ https://www.ncbi.nlm.nih.gov/pubmed/32095513 http://dx.doi.org/10.1097/TXD.0000000000000973 |
Ejemplares similares
-
Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease
por: Gabriëls, Ruben Y., et al.
Publicado: (2022) -
Luminal Preservation Protects the Small Intestine in a Brain-dead Rat Model
por: Trentadue, Guido, et al.
Publicado: (2022) -
Initial Experience of Video Capsule Endoscopy After Intestinal Transplantation
por: Varkey, Jonas, et al.
Publicado: (2016) -
Robotic-Assisted Live Donor Ileal Segmentectomy for Intestinal Transplantation
por: Wu, Guosheng, et al.
Publicado: (2017) -
Identical Twin Small-bowel Transplantation Without Maintenance Immunosuppression: A 5-year Follow-up and Literature Review
por: Wu, Guosheng, et al.
Publicado: (2018)